By the TutelaMedical.com Editorial Team | This article is for educational purposes only and does not constitute medical advice. These statements have not been evaluated by the Food and Drug Administration. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before starting any new supplement.
What Is Memopryl
Memopryl is a daily dietary supplement in capsule form, marketed as a nootropic — a class of compounds studied for their potential to support cognitive function, memory, focus, and mental clarity in healthy adults. It is distributed by MemoPryl Research, sold through ClickBank as the authorized payment processor, and available exclusively through the official website at memopryl.com. The brand states it is manufactured in an FDA-registered, GMP-certified facility, which is a brand claim rather than an independently verified certification.
The product is positioned for adults experiencing the cognitive changes that accompany aging — reduced sharpness, slower word retrieval, difficulty sustaining concentration — as well as professionals and individuals seeking proactive cognitive maintenance. It is not a medication. It has no FDA-approved indication. No randomized controlled trial of the finished Memopryl formula has been published. That separator applies to every section that follows.
Memopryl contains eight named ingredients. What makes this formula structurally distinctive is not any single compound — it is the deliberate pairing of three ingredients that all target the same neurochemical system. Understanding how these eight ingredients work individually, and how three of them work together, is the most useful thing a potential buyer can take away from this overview.
The Eight Ingredients
Ginkgo Biloba is derived from the leaves of the Ginkgo biloba tree and is one of the most commercially studied botanicals in cognitive health research. Its active compounds — flavone glycosides and terpene lactones — are investigated for two primary mechanisms: supporting cerebral blood flow and providing antioxidant protection at the neuronal level. Improved circulation to the brain means better delivery of oxygen and glucose to neural tissue; the antioxidant activity addresses oxidative stress, which accumulates in neural cells over time. The research record is extensive and genuinely mixed. In populations already experiencing age-related cognitive changes, standardized Ginkgo extract has shown more consistent outcomes than in healthy younger adults. The large GEM (Ginkgo Evaluation of Memory) study found limited preventive benefit in healthy older adults; other trials with EGb 761 standardized extract at adequate doses over 24 weeks or longer have shown more supportive cognitive outcomes. The quality of any Ginkgo product depends substantially on standardization — whether it is extracted to consistent flavone glycoside and terpenoid percentages. Memopryl does not publicly disclose this information for its Ginkgo component. This is ingredient-level research and does not apply to the finished Memopryl formula.
Phosphatidylserine is a phospholipid found naturally in brain cell membranes, where it plays a structural role in maintaining cellular integrity and facilitating efficient neurotransmitter signaling. It is one of the few nootropic ingredients for which the FDA has acknowledged a qualified health claim — specifically related to cognitive function and reduced dementia risk — carrying the required qualifier that evidence is “limited and not conclusive.” That distinction matters: the FDA's acknowledgment signals meaningful research exists while being appropriately precise about its strength. Studies have examined its role in supporting synaptic plasticity and neurotransmitter release. This is ingredient-level research and does not apply to the finished Memopryl formula.
Bacopa Monnieri Extract is arguably the most consistently researched botanical ingredient in the Memopryl formula. Its active compounds — bacosides — have been studied in multiple randomized controlled trials. A 2014 meta-analysis in the Journal of Ethnopharmacology, examining 9 RCTs with 518 subjects, found standardized Bacopa extract showed potential to improve cognition, particularly attentional speed. Clinical trials have typically used 300 to 450 mg of standardized extract daily for at least 12 weeks. The time requirement is not a footnote — it is central to how this ingredient behaves. Bacopa's mechanism involves gradual accumulation of bacosides in neural tissue. Evaluating a Bacopa-containing supplement over less than 8 weeks provides no meaningful data on whether the ingredient is performing. Memopryl's 60-day guarantee aligns reasonably with a minimum evaluation window, though 90 days is closer to the timeline most clinical research used. This is ingredient-level research and does not apply to the finished Memopryl formula.
N-Acetyl-L-Carnitine (ALCAR) is a form of the amino acid L-Carnitine that crosses the blood-brain barrier. Its primary area of research involves brain energy metabolism — specifically, facilitating the transport of fatty acids into neuronal mitochondria for conversion into cellular energy. Research has also explored its potential neuroprotective effects and its relationship to acetylcholine synthesis pathways, which places it in the cholinergic system alongside two other Memopryl ingredients. The cognitive complaint most addressed by ALCAR's mechanism is mental fatigue — the sense of running low on cognitive fuel through a demanding day — rather than memory or attention deficits in isolation. This is ingredient-level research and does not apply to the finished Memopryl formula.
St. John's Wort is a botanical with a documented research history in mood and emotional well-being. Its active compounds — hypericin and hyperforin — interact with serotonin and dopamine pathways. Its inclusion in a nootropic formula reflects the physiologically documented relationship between emotional state and cognitive performance: sustained stress, low mood, and emotional depletion all measurably impair cognitive function. This is the ingredient with the most significant safety consideration in the Memopryl formula and warrants specific attention in this overview. St. John's Wort induces cytochrome P450 enzymes — particularly CYP3A4 and CYP2C9 — that the body uses to metabolize a wide range of prescription medications. This can reduce the effectiveness of numerous drug categories. Combinations with SSRIs and MAOIs (antidepressants) can cause serotonin syndrome. Anyone taking prescription medication of any kind should review the complete interaction profile and consult a physician before using any supplement containing St. John's Wort. The Memopryl safety guide covers this interaction profile in full. This is ingredient-level research and does not apply to the finished Memopryl formula.
L-Glutamine is a conditionally essential amino acid that serves as a precursor for both glutamate — the brain's primary excitatory neurotransmitter — and GABA, the primary inhibitory neurotransmitter. The balance between these two chemicals underlies the neurochemical conditions for focused attention, calm concentration, and effective cognitive filtering. Research has examined L-Glutamine's role in maintaining brain energy homeostasis and supporting neurotransmitter balance during high-demand cognitive periods. This is ingredient-level research and does not apply to the finished Memopryl formula.
Alpha-GPC (Alpha-Glycerophosphorylcholine) is a choline-containing compound and one of the most bioavailable choline sources available in supplement form. The brain converts choline into acetylcholine — the neurotransmitter most directly associated with memory formation, learning, and attention. Alpha-GPC's ability to efficiently cross the blood-brain barrier and deliver choline to neural tissue is what makes it one of the more mechanistically specific ingredients in this category. It is the “precursor supply” component of Memopryl's cholinergic triple-pathway design. This is ingredient-level research and does not apply to the finished Memopryl formula.
Huperzine-A is a natural alkaloid from Huperzia serrata (firmoss) that works as an acetylcholinesterase inhibitor — it slows the enzymatic breakdown of acetylcholine, extending the duration that acetylcholine remains active in synaptic clefts. This mechanism is the “preservation” component of the cholinergic triple-pathway design. Alpha-GPC builds acetylcholine supply; ALCAR supports its synthesis pathways; Huperzine-A prevents its rapid degradation. This three-part approach to acetylcholine availability is the central formulation logic of Memopryl. This is ingredient-level research and does not apply to the finished Memopryl formula.
What the Formula Architecture Tells You
Reading these eight ingredients as a group — not as individuals — reveals the formulation intent. The foundation is cholinergic: three ingredients targeting acetylcholine availability through three separate mechanisms. Layered around that foundation are cerebral blood flow support (Ginkgo), membrane integrity and synaptic function (Phosphatidylserine), memory consolidation (Bacopa), neurotransmitter balance (L-Glutamine), and mood-cognition axis support (St. John's Wort). This is a multi-mechanism approach covering several of the major pathways implicated in age-related cognitive change.
The limitation that cannot be resolved from ingredient analysis alone is dosage. Memopryl does not publicly disclose how much of each ingredient is in each serving. Whether the Bacopa is dosed within the range used in the 12-week clinical trials, whether the Huperzine-A is at a level known to cause GI effects in sensitive individuals, whether the Phosphatidylserine reaches the threshold relevant to the FDA's qualified health claim — none of this can be assessed without the Supplement Facts panel dosage data. Ingredient identity confirms what the formula is designed to do. Dosage determines whether the formula is designed to do it effectively.
For a detailed evidence-level breakdown of the research behind each compound, see the Memopryl ingredients analysis. For a full safety and drug interaction profile, see the Memopryl safety guide. For a broader look at where nootropic ingredients rank in the current evidence base, TutelaMedical.com's independent nootropic rankings cover 13 compounds and products with research-graded assessments. For context on Memopryl's formula relative to the Memopryl main review, see the Memopryl editorial review. For a comparison of Memopryl against similar products, see the Memo Clarity review.
Frequently Asked Questions
What are the ingredients in Memopryl?
Memopryl contains eight ingredients: Ginkgo Biloba, Phosphatidylserine, Bacopa Monnieri Extract, N-Acetyl-L-Carnitine (ALCAR), St. John's Wort, L-Glutamine, Alpha-GPC, and Huperzine-A. Per-ingredient milligram dosages are not publicly disclosed on the official website.
How does Memopryl work?
Memopryl is formulated around three primary mechanisms: cholinergic system support through Alpha-GPC, ALCAR, and Huperzine-A; cerebral blood flow support through Ginkgo Biloba; and memory consolidation support through Bacopa Monnieri and Phosphatidylserine. The combination targets multiple cognitive pathways rather than a single mechanism.
Is Memopryl a prescription drug?
No. Memopryl is a dietary supplement, not an FDA-approved drug or prescription medication. These statements have not been evaluated by the Food and Drug Administration. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease.